PT - JOURNAL ARTICLE AU - Takahiro Watanabe AU - Shinichi Noto AU - Manabu Natsumeda AU - Shinji Kimura AU - Satoshi Tabata AU - Fumie Ikarashi AU - Mayuko Takano AU - Yoshihiro Tsukamoto AU - Makoto Oishi TI - Characteristics of health-related quality of life and related factors in patients with brain tumors treated with rehabilitation therapy AID - 10.1101/2022.04.25.22274293 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.25.22274293 4099 - http://medrxiv.org/content/early/2022/04/28/2022.04.25.22274293.short 4100 - http://medrxiv.org/content/early/2022/04/28/2022.04.25.22274293.full AB - Background Rehabilitation therapy during hospitalization is effective in improving activities of daily living (ADL) and physical function in patients with brain tumors. However, there are few studies on the effect of rehabilitation therapy on health-related quality of life (HRQOL) in patients with brain tumors. Additionally, the EuroQol-5Dimension-5Level (EQ-5D-5L) index score has not been reported as an outcome. This study aimed to investigate the HRQOL of patients with brain tumors who underwent rehabilitation therapy and investigated the factors affecting the EQ-5D-5L index score from various perspectives, including various brain tumor types, treatment methods, and recurrence. In addition, we examined the relationship between the EQ-5D-5L index score, disease-specific HRQOL scale, and ADL.Methods Patients with brain tumors who underwent treatment and rehabilitation at Niigata University Medical & Dental Hospital were included in this cross-sectional study. We used the EQ-5D-5L, European Organisation for Research and Treatment of Cancer (EORTC) quality of life questionnaire core 30, and EORTC quality of life questionnaire brain cancer module to evaluate HRQOL. ADL were assessed using the functional independence measure (FIM). The relationship between each HRQOL assessment score and the FIM was analyzed, and the influence of related factors was assessed by multiple regression analysis.Results This study included 76 patients. The EQ-5D-5L index score was 0.689 for all patients with brain tumors and 0.574 for those with glioblastomas, which was the lowest value. There was a strong correlation between the EQ-5D-5L index score and FIM (r = 0.627, p<0.001). In addition, the EQ-5D-5L index score was significantly correlated with most of the items of the disease-specific HRQOL scale. Multiple regression analysis revealed that glioblastoma histology (coefficient: -0.570, p = 0.024) and surgery (coefficient: 0.376, p = 0.030) were independent factors affecting the EQ-5D-5L index score.Conclusions Patients with glioblastoma undergoing rehabilitation may have reduced HRQOL, which was influenced by glioblastoma histology and surgery.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Niigata University Ethical Review Committee (Approval No.: 2020-0380).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableData cannot be shared publicly because of privacy for the patients.